A61P 15/00
Drugs for genital or sexual disorders
Official title: Drugs for genital or sexual disorders (for disorders of sex hormones A61P5/24); Contraceptives
A61P15/00 (Drugs for genital or sexual disorders) appears on 17,298 US grants and 24,443 published applications in this corpus.
Search patents in A61P- Granted patents
- 17,298
- Published applications
- 24,443
- Assignees
- 6,288
- Inventors
- 36,405
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 13 | 0 |
| 1978 | 22 | 0 |
| 1979 | 7 | 0 |
| 1980 | 13 | 0 |
| 1981 | 22 | 0 |
| 1982 | 18 | 0 |
| 1983 | 13 | 0 |
| 1984 | 14 | 0 |
| 1985 | 18 | 0 |
| 1986 | 22 | 0 |
| 1987 | 23 | 0 |
| 1988 | 34 | 0 |
| 1989 | 58 | 0 |
| 1990 | 74 | 0 |
| 1991 | 81 | 0 |
| 1992 | 78 | 0 |
| 1993 | 102 | 0 |
| 1994 | 94 | 0 |
| 1995 | 156 | 0 |
| 1996 | 182 | 0 |
| 1997 | 238 | 0 |
| 1998 | 290 | 0 |
| 1999 | 301 | 0 |
| 2000 | 342 | 0 |
| 2001 | 368 | 116 |
| 2002 | 463 | 615 |
| 2003 | 426 | 968 |
| 2004 | 358 | 1252 |
| 2005 | 359 | 1198 |
| 2006 | 554 | 1150 |
| 2007 | 474 | 1230 |
| 2008 | 595 | 1376 |
| 2009 | 607 | 1560 |
| 2010 | 870 | 1658 |
| 2011 | 827 | 1401 |
| 2012 | 950 | 1361 |
| 2013 | 1053 | 1189 |
| 2014 | 1014 | 1242 |
| 2015 | 927 | 1159 |
| 2016 | 784 | 1106 |
| 2017 | 820 | 988 |
| 2018 | 700 | 883 |
| 2019 | 635 | 802 |
| 2020 | 598 | 709 |
| 2021 | 445 | 574 |
| 2022 | 343 | 484 |
| 2023 | 266 | 466 |
| 2024 | 259 | 405 |
| 2025 | 250 | 341 |
| 2026 | 131 | 210 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- A61P 15/08Drugs for genital or sexual disorders: for gonadal disorders or for enhancing3,478
- A61P 15/10Drugs for genital or sexual disorders: for impotence2,977
- A61P 15/02Drugs for genital or sexual disorders: for disorders of the vagina1,125
- A61P 15/18Feminine contraceptives1,051
- A61P 15/12Drugs for genital or sexual disorders: for climacteric disorders955
- A61P 15/06Antiabortive agents922
- A61P 15/16Masculine contraceptives539
- A61P 15/14Drugs for genital or sexual disorders: for lactation disorders471
All 9 subgroupsShow fewer
Recent patents
- Method of treating a child with central precocious puberty using an extended release composition6 Oct 2026US 12,751,990 B2Tolmar International Limited
- Cannabinoids and uses thereof for treatment of estrogen receptor related diseases22 Sep 2026US 12,740,993 B2Technion Research & Development Foundation Limited
- Fused polycyclic substituted 5-carboxylic acid thienopyrimidine dione compound and use thereof22 Sep 2026US 12,741,975 B2Cms Research & Development Pte. Ltd.
- Progesterone formulation to trigger ovulation and provide luteal phase support15 Sep 2026US 12,734,179 B2Augusta University Research Institute, Inc.
- Treatment of prostate cancer with a combination of abiraterone acetate, niraparib tosylate monohydrate and prednisone15 Sep 2026US 12,734,180 B2Janssen Pharmaceutica NV
- Methods for using bacteria and host/microbiota-derived metabolites for diagnosis and treatment of endometriosis8 Oct 2026US 2026/0306451 A1Baylor College of Medicine
- Compositions and methods for the treatment of congenital adrenal hyperplasia8 Oct 2026US 2026/0306485 A1Crinetics Pharmaceuticals, Inc.
- Dna aptamer capable of selectively binding to soluble flt-1 and carrier having said dna aptamer immobilized thereto8 Oct 2026US 2026/0308600 A1Tagcyx Biotechnologies
- Ketamine for the treatment of menstrually related symptoms1 Oct 2026US 2026/0294843 A1
- Compositions and methods for treating vulvar and vaginal atrophy (vva)1 Oct 2026US 2026/0294846 A1
Most cited
By later US patents
- Gum pad for delivery of medication to mucosal tissues1,140US 6,319,510 B12001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Injectable or implantable biomaterials for filling or blocking lumens and voids of the body846US 5,752,974 ACollagen Corporation · 1998
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents617US 6,294,192 B1Lipocine Inc. · 2001